EUVIMEDEUVIMED entdecken
Open Access

Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae

Daisuke Suzuki iD, Aki Sakurai iD, Mitsutaka Wakuda, Masahiro Suzuki iD, Yohei Doi iD

Antimicrobial Agents and Chemotherapy · 02.05.2024 · 68 (5)

DOI: 10.1128/aac.01672-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 02.05.2024. Verfasst von Daisuke Suzuki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, beta-Lactamases, Enterobacter cloacae, Anti-Bacterial Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, MEXT | Japan Society for the Promotion of Science, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenemase-producing Enterobacterales (CPEs) are one of the top priority antimicrobial-resistant pathogens. Among CPEs, those producing acquired metallo-β-lactamases (MBLs) are considered particularly problematic as few agents are active against them. Imipenemase (IMP) is the most frequently encountered acquired MBL in Japan, but comprehensive assessment of clinical and microbiological features of IMP-producing Enterobacterales infection remains scarce. Here, we retrospectively evaluated 62 patients who were hospitalized at a university hospital in Japan and had IMP-producing Enterobacterales from a clinical culture. The isolates were either Enterobacter cloacae complex or Klebsiella pneumoniae , and most of them were isolated from sputum. The majority of K. pneumoniae, but not E. cloacae complex isolates, were susceptible to aztreonam. Sequence type (ST) 78 and ST517 were prevalent for E. cloacae complex and K. pneumoniae , respectively, and all isolates carried bla IMP-1 . Twenty-four of the patients were deemed infected with IMP-producing Enterobacterales . Among the infected patients, therapy varied and largely consisted of conventional β-lactam agents, fluoroquinolones, or combinations. Three (13%), five (21%), and nine (38%) of them died by days 14, 30, and 90, respectively. While incremental mortality over 90 days was observed in association with underlying comorbidities, active conventional treatment options were available for most patients with IMP-producing Enterobacterales infections, distinguishing them from more multidrug-resistant CPE infections associated with globally common MBLs, such as New Delhi metallo-β-lactamase (NDM) and Verona integron-encoded metallo-β-lactamase (VIM).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaebeta-LactamasesEnterobacter cloacaeAnti-Bacterial AgentsMicrobial Sensitivity TestsBacterial ProteinsHumansMaleRetrospective StudiesFemaleMiddle AgedAgedEnterobacteriaceae InfectionsAztreonamJapanDrug Resistance, Multiple, BacterialKlebsiella InfectionsAged, 80 and overAdult

Stichwörter der Autor:innen

carbapenemase-producing Enterobacteralesclinical outcomegenome epidemiologymetallo-beta-lactamase

Substanzen

beta-LactamasesAnti-Bacterial AgentsBacterial ProteinsAztreonamcarbapenemase

Autor:innen und Institutionen

  • Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Anjo Kosei Hospital, Anjo, Aichi, Japan.
  • Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University Hospital, Toyoake, Japan.
  • Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Daisuke Suzuki, Aki Sakurai, Masahiro Suzuki, Yohei Doi

Förderung

  • NIAID NIH HHS
  • MEXT | Japan Society for the Promotion of Science
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Suzuki, D., Sakurai, A., Wakuda, M., Suzuki, M., & Doi, Y. (2024). Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 68(5). https://doi.org/10.1128/aac.01672-23

Vancouver

Suzuki D, Sakurai A, Wakuda M, Suzuki M, Doi Y. Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 2024;68(5). doi:10.1128/aac.01672-23

BibTeX
@article{Suzuki2024,
  author = {Suzuki, Daisuke and Sakurai, Aki and Wakuda, Mitsutaka and Suzuki, Masahiro and Doi, Yohei},
  title = {Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  volume = {68},
  number = {5},
  doi = {10.1128/aac.01672-23}
}
Kostenlos starten →